InventisBio Revenue

In the year 2025, InventisBio had annual revenue of 37.33M CNY, down -77.89%. InventisBio had revenue of 6.43M in the quarter ending December 31, 2025, a decrease of -95.70%.

Revenue

37.33M

Revenue Growth

-77.89%

P/S Ratio

334.07

Revenue / Employee

201.76K

Employees

168

Market Cap

12.47B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	37.33M	-131.47M	-77.89%
Dec 31, 2024	168.79M	-16.74M	-9.02%
Dec 31, 2023	185.53M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Staidson (Beijing) BioPharmaceuticals	244.37M
Beijing Hotgen Biotech	407.69M
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong	16.62B
Chengdu Olymvax Biopharmaceuticals	704.16M
Hualan Biological Vaccine	976.44M
Pacific Shuanglin Bio-pharmacy	2.38B
Mabwell (Shanghai) Bioscience	662.52M
Vcanbio Cell & Gene Engineering Corp.,	1.47B

Revenue Rankings